These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6692287)

  • 21. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
    Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
    J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen in premenopausal patients with metastatic breast cancer: a review.
    Sunderland MC; Osborne CK
    J Clin Oncol; 1991 Jul; 9(7):1283-97. PubMed ID: 2045868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the effect of premenopausal oophorectomy on bone mineral content].
    Ueno N; Kato Y; Masuda R; Amano K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):308-12. PubMed ID: 2786541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG; Nielsen LP; Mogensen NB
    Nephron; 1983; 35(2):103-7. PubMed ID: 6621754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
    Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
    Aihara T; Suemasu K; Takei H; Hozumi Y; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
    Oncology; 2010; 79(5-6):376-81. PubMed ID: 21430407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen-induced remission in breast cancer by escalating the dose to 40 mg daily after progression on 20 mg daily: a case report and review of the literature.
    Manni A; Arafah BM
    Cancer; 1981 Aug; 48(4):873-5. PubMed ID: 7272931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
    Masuda N; Sagara Y; Kinoshita T; Iwata H; Nakamura S; Yanagita Y; Nishimura R; Iwase H; Kamigaki S; Takei H; Noguchi S
    Lancet Oncol; 2012 Apr; 13(4):345-52. PubMed ID: 22265697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long term tamoxifen treatment on bone turnover in women with breast cancer.
    Wright CD; Mansell RE; Gazet JC; Compston JE
    BMJ; 1993 Feb; 306(6875):429-30. PubMed ID: 8461725
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistence of diminished bone mineral content following renal transplantation in childhood.
    Chesney RW; Rose PG; Mazess RB
    Pediatrics; 1984 Apr; 73(4):459-66. PubMed ID: 6369239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
    Wagner-Johnston ND; Sloan JA; Liu H; Kearns AE; Hines SL; Puttabasavaiah S; Dakhil SR; Lafky JM; Perez EA; Loprinzi CL
    Cancer; 2015 Aug; 121(15):2537-43. PubMed ID: 25930719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
    Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.
    Ribeiro G; Palmer MK
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):827-30. PubMed ID: 6403101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of advanced breast cancer with multiple organ metastases successfully treated by tamoxifen].
    Shiba E; Kobayashi T; Takeda T; Miya A; Kawano I; Takai S; Mori T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2255-8. PubMed ID: 1444494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen-induced hypercalcemia in breast cancer.
    Legha SS; Powell K; Buzdar AU; Blumenschein GR
    Cancer; 1981 Jun; 47(12):2803-6. PubMed ID: 7260871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of postmenopausal primary hyperparathyroidism during adjuvant tamoxifen for breast cancer.
    Kristensen B; Mouridsen HT; Holmegaard SN; Transbøl I
    Cancer; 1989 Nov; 64(9):1965-7. PubMed ID: 2790705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.